Long Term Barrett's Endoscopic Mucosal Resection Study

Long Term Outcomes of Patients Undergoing Endoscopic Resection of Barrett's Oesophagus (BO) With High Grade Dysplasia (HGD) and Early Adenocarcinoma

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02200250

Acronym

CBE

Enrollment

Registered

2014-07-25

Start date

2021-10-01

Completion date

2022-10-31

Last updated

2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barretts Esophagus

Brief summary

Analysis of long term outcomes of patients undergoing endoscopic mucosal resection for Barrett's oesophagus with high grade dysplasia and/or early intramucosal carcinoma (IMC).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* 18 years or over * Have or have had Barrett's Oesophagus

Exclusion criteria

* Do not have Barrett's Oesophagus * Have not had Barrett's Oesophagus resected at Westmead Hospital

Design outcomes

Primary

Measure	Time frame	Description
Reviewing patients symptoms following resection	up to 3 years	Patients will be contacted via phone and will be required to answer questions over the phone. Health questionnaires may also be sent at the patients request to complete and post back.

Countries

Australia

Outcome results